A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide In Subjects with Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets with Insulin Therapy
- Karounos, Dennis (PI)
- Anderson, James (CoI)
- Reynolds, L (CoI)